FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200222101> ?p ?o ?g. }

• W4200222101 endingPage "908" @default.
• W4200222101 startingPage "899" @default.
• W4200222101 abstract "The role of plasma exchange in treatment of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) with severe kidney involvement is controversial. It is urgent to find effective treatments to improve prognosis of AAV patients. In this retrospective study, the outcomes of immunoadsorption (IA) onto protein A in AAV patients with severe kidney involvement were evaluated.Clinical data of 60 patients with AAV and severe kidney involvement were analyzed. Patients received cyclophosphamide or rituximab for remission induction, among which 16 were additionally treated with IA. Remission, end-stage kidney disease (ESKD), death, and relapse were compared.Of 60 patients, 56 patients (93.3%) were positive for myeloperoxidase (MPO)-ANCA. At diagnosis, the estimated glomerular filtration rate and Birmingham Vasculitis Activity Score (BVAS) was 13.0 (7.7, 18.7) mL/min/1.73 m2 and 11.1 ± 3.4, respectively. After 3-17 days (mean 10.4 days) of induction treatment, the disease activity decreased more obviously in the IA group (p = 0.022) than the control group. IA showed superior over standard regimen in clearance of MPO-ANCA within 3-31 days (median 11 days) after treatment (78.4% vs. 9.3%, p = 0.005). After a median follow-up of 20.2 months, remission was achieved more quickly (p = 0.035) and higher (hazard ratio (HR) = 2.3, 95% confidence interval (CI): 1.1∼7.2, p = 0.033) in the IA group than the control group. IA therapy showed an advantage in reducing death (HR = 0.2, 95% CI: 0.1∼0.9, p = 0.032). There was no difference in developing into ESKD in both groups (HR = 0.7, 95% CI: 0.3∼2.0, p = 0.504). Multivariate Cox regression analysis indicated that early-stage remission was an independent predictor for ESKD (HR = 0.03, 95% CI: 0.003∼0.25, p = 0.001) and death (HR = 0.07, 95% CI: 0.01∼0.51, p = 0.009).IA treatment induces quicker and higher remission and lower mortality in AAV patients with severe kidney involvement. The early remission independently predicts the outcomes for these patients." @default.
• W4200222101 created "2021-12-31" @default.
• W4200222101 creator A5023134700 @default.
• W4200222101 creator A5027213805 @default.
• W4200222101 creator A5033056656 @default.
• W4200222101 creator A5047068303 @default.
• W4200222101 creator A5052318748 @default.
• W4200222101 creator A5056204035 @default.
• W4200222101 creator A5064719218 @default.
• W4200222101 creator A5065884417 @default.
• W4200222101 creator A5077453513 @default.
• W4200222101 creator A5090693444 @default.
• W4200222101 creator A5091794248 @default.
• W4200222101 date "2021-01-01" @default.
• W4200222101 modified "2023-09-26" @default.
• W4200222101 title "Immunoadsorption Improves Remission Rates of Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and Severe Kidney Involvement" @default.
• W4200222101 cites W137802152 @default.
• W4200222101 cites W1988623007 @default.
• W4200222101 cites W1992270926 @default.
• W4200222101 cites W1994314834 @default.
• W4200222101 cites W2009150197 @default.
• W4200222101 cites W2010507354 @default.
• W4200222101 cites W2011557149 @default.
• W4200222101 cites W2019661033 @default.
• W4200222101 cites W2025060860 @default.
• W4200222101 cites W2031517139 @default.
• W4200222101 cites W2045143849 @default.
• W4200222101 cites W2057194530 @default.
• W4200222101 cites W2057250060 @default.
• W4200222101 cites W2062964048 @default.
• W4200222101 cites W2063340779 @default.
• W4200222101 cites W2069960546 @default.
• W4200222101 cites W2078603633 @default.
• W4200222101 cites W2084056567 @default.
• W4200222101 cites W2096605226 @default.
• W4200222101 cites W2100809783 @default.
• W4200222101 cites W2110876894 @default.
• W4200222101 cites W2112131279 @default.
• W4200222101 cites W2113043267 @default.
• W4200222101 cites W2113281485 @default.
• W4200222101 cites W2119545985 @default.
• W4200222101 cites W2120427700 @default.
• W4200222101 cites W2123180572 @default.
• W4200222101 cites W2124208349 @default.
• W4200222101 cites W2132795660 @default.
• W4200222101 cites W2147350349 @default.
• W4200222101 cites W2151319492 @default.
• W4200222101 cites W2155965977 @default.
• W4200222101 cites W2161045147 @default.
• W4200222101 cites W2163488378 @default.
• W4200222101 cites W2171643265 @default.
• W4200222101 cites W2442493508 @default.
• W4200222101 cites W2581458651 @default.
• W4200222101 cites W2603618866 @default.
• W4200222101 cites W2607031541 @default.
• W4200222101 cites W2953058635 @default.
• W4200222101 cites W2964713081 @default.
• W4200222101 cites W2985640274 @default.
• W4200222101 cites W3004897282 @default.
• W4200222101 cites W3080098141 @default.
• W4200222101 cites W3115205291 @default.
• W4200222101 cites W3117869582 @default.
• W4200222101 doi "https://doi.org/10.1159/000519608" @default.
• W4200222101 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34875652" @default.
• W4200222101 hasPublicationYear "2021" @default.
• W4200222101 type Work @default.
• W4200222101 citedByCount "5" @default.
• W4200222101 countsByYear W42002221012022 @default.
• W4200222101 countsByYear W42002221012023 @default.
• W4200222101 crossrefType "journal-article" @default.
• W4200222101 hasAuthorship W4200222101A5023134700 @default.
• W4200222101 hasAuthorship W4200222101A5027213805 @default.
• W4200222101 hasAuthorship W4200222101A5033056656 @default.
• W4200222101 hasAuthorship W4200222101A5047068303 @default.
• W4200222101 hasAuthorship W4200222101A5052318748 @default.
• W4200222101 hasAuthorship W4200222101A5056204035 @default.
• W4200222101 hasAuthorship W4200222101A5064719218 @default.
• W4200222101 hasAuthorship W4200222101A5065884417 @default.
• W4200222101 hasAuthorship W4200222101A5077453513 @default.
• W4200222101 hasAuthorship W4200222101A5090693444 @default.
• W4200222101 hasAuthorship W4200222101A5091794248 @default.
• W4200222101 hasBestOaLocation W42002221011 @default.
• W4200222101 hasConcept C126322002 @default.
• W4200222101 hasConcept C141071460 @default.
• W4200222101 hasConcept C159641895 @default.
• W4200222101 hasConcept C159654299 @default.
• W4200222101 hasConcept C203014093 @default.
• W4200222101 hasConcept C207103383 @default.
• W4200222101 hasConcept C24040308 @default.
• W4200222101 hasConcept C2776015282 @default.
• W4200222101 hasConcept C2776694085 @default.
• W4200222101 hasConcept C2776755627 @default.
• W4200222101 hasConcept C2778653478 @default.
• W4200222101 hasConcept C2778910314 @default.
• W4200222101 hasConcept C2779134260 @default.
• W4200222101 hasConcept C2779338263 @default.
• W4200222101 hasConcept C2779839709 @default.
• W4200222101 hasConcept C2780653079 @default.

• next